Synergistic activity of ixabepilone plus other anticancer agents: preclinical and clinical evidence
出版年份 2010 全文链接
标题
Synergistic activity of ixabepilone plus other anticancer agents: preclinical and clinical evidence
作者
关键词
-
出版物
Therapeutic Advances in Medical Oncology
Volume 3, Issue 1, Pages 11-25
出版商
SAGE Publications
发表日期
2010-10-21
DOI
10.1177/1758834010386402
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Role of a second chemotherapy in recurrent malignant glioma patients who progress on a bevacizumab-containing regimen
- (2017) E. Quant et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small cell lung cancer.
- (2017) D. Shipley et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized phase II study of weekly versus every 3 week ixabepilone plus bevacizumab (ixa/bev) versus paclitaxel plus bev (pac/bev) as first-line therapy for metastatic breast cancer (MBC): Final results.
- (2017) H. S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- Antiangiogenic (AG) Synergy with Ixabepilone (IXA): Translation of Preclinical Studies to the Clinical Setting.:
- (2010) F. Lee et al. CANCER RESEARCH
- Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2010) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial
- (2009) Stacy Moulder et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P
- (2009) Don S. Dizon et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
- (2009) Koen De Geest et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical discovery of ixabepilone, a highly active antineoplastic agent
- (2008) Francis Y. F. Lee et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Preclinical efficacy spectrum and pharmacokinetics of ixabepilone
- (2008) Francis Y. F. Lee et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors
- (2008) Dorte Lisbet Nielsen et al. CANCER TREATMENT REVIEWS
- Phase I/II Study of Ixabepilone plus Capecitabine in Anthracycline–Pretreated/Resistant and Taxane-Resistant Metastatic Breast Cancer
- (2008) Craig Bunnell et al. Clinical Breast Cancer
- Ixabepilone in Combination with Capecitabine and as Monotherapy for Treatment of Advanced Breast Cancer Refractory to Previous Chemotherapies
- (2008) R. J. Lechleider et al. CLINICAL CANCER RESEARCH
- Synergistic Antitumor Activity of Ixabepilone (BMS-247550) Plus Bevacizumab in Multiple In vivo Tumor Models
- (2008) F. Y.F. Lee et al. CLINICAL CANCER RESEARCH
- Bevacizumab in Non-Small Cell Lung Cancer
- (2008) Francesco Di Costanzo et al. DRUGS
- Clinical Development of Ixabepilone and Other Epothilones in Patients with Advanced Solid Tumors
- (2008) E. Rivera et al. ONCOLOGIST
- Triple-negative/basal-like breast cancer: review
- (2008) Emad A. Rakha et al. PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now